T 2524/10 (Purification process/CRYSTAL PHARMA, S.A.) of 23.07.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T252410.20120723
- Date of decision
- 23 July 2012
- Case number
- T 2524/10
- Online on
- 30 July 2012
- Petition for review of
- -
- Application number
- 04703805.4
- IPC class
- C07J 21/00C07J 41/00C07J 7/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method of obtaining 17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
- Applicant name
- Crystal Pharma, S.A.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step -(yes) - unexpected higher purity grade
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to grant a patent with the present main request and a description to be adapted.